As Chief Manufacturing Officer, Starr will drive the development and deployment of a network of between 12 and 15 pilot- to intermediate-scale bioindustrial manufacturing facilities, including BioMADE’s recently announced site in Minnesota . The United States is poised to be the global leader in bioindustrial manufacturing, and these critically...

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) officially launches the Viral Vectors NIIMBL-led Program focused on developing and making broadly available robust, economically viable, shared manufacturing process and analytical platforms for Adeno-Associated Virus (AAV) gene therapy vectors. NIIMBL has committed...

BioMADE, in partnership with member Delgado Community College , received a National Science Foundation grant to develop pioneering new industry-driven curricula for bioindustrial manufacturing that will build the technical workforce needed to support this growing sector.

The goals of this project are to:

Develop, test, and finalize key...

BioMADE will be investing in state-of-the-art bioindustrial manufacturing infrastructure in Minnesota, following support of up to $100 million from Governor Tim Walz and the Minnesota Legislature in the 2023 legislative session. The forthcoming biomanufacturing infrastructure investments in Minnesota will be the first start in a national network of...

BioMADE is excited to announce five new projects that focus on developing more efficient, lower-cost, flexible, and re-deployable bioreactors to advance the U.S. bioeconomy and biomanufacturing goals. Project teams led by members Capra Biosciences, Amyris, Geno, and two teams from Iowa State University propose technological innovations in...